Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  223.77
-2.42 (-1.07%)
AAPL  274.70
-3.58 (-1.29%)
AMD  212.95
+2.17 (1.03%)
BAC  55.52
+0.38 (0.70%)
GOOG  308.57
-1.94 (-0.63%)
META  648.65
+4.42 (0.69%)
MSFT  474.75
-3.78 (-0.79%)
NVDA  177.68
+2.66 (1.52%)
ORCL  184.61
-5.36 (-2.82%)
TSLA  478.46
+19.50 (4.25%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.